Chimerix, Inc.
2505 Meridian Parkway
Ste 340
Durham
North Carolina
27713
United States
Tel: 919-806-1074
Fax: 919-806-1146
Website: http://www.chimerix-inc.com/
309 articles about Chimerix, Inc.
-
Chimerix, Inc. Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
1/6/2009
-
Chimerix, Inc. Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
1/3/2008
-
Chimerix, Inc. Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection
12/11/2007
-
Chimerix, Inc. Raises $23.1 Million To Advance Antiviral Drug Pipeline
2/23/2007
-
Chimerix, Inc. Announces Initiation Of Phase I Clinical Trials Of CMX001, An Oral Treatment For Smallpox Infection
6/28/2006
-
Chimerix, Inc. Acquires Lead Compound Library Of Antiviral Agents From University of Michigan
5/24/2006
-
Chimerix, Inc. And USAMRIID Collaborate To Complete Preclinical Development Of Smallpox Therapeutic
4/18/2006
-
Chimerix, Inc. Announces Selection As A Top 5 Nominee For 2005 World Technology Award In Health and Medicine
11/10/2005
-
Chimerix, Inc. Supports Biodefense Legislation To Accelerate And Innovate Counterterrorism Products
11/3/2005